Lewis James D, Albenberg Lindsey, Lee Dale, Kratz Mario, Gottlieb Klaus, Reinisch Walter
*Division of Gastroenterology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; †Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; ‡Division of Gastroenterology, Hepatology, and Nutrition, Seattle Children's Hospital, University of Washington, Seattle, Washington; §Public Health Sciences Division, Departments of Epidemiology and Medicine, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; ‖George Washington University, Washington, DC; ¶Division of Gastroenterology and Hepatology, McMaster University, Hamilton, Ontario, Canada; and **Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Inflamm Bowel Dis. 2017 Feb;23(2):181-191. doi: 10.1097/MIB.0000000000001009.
Inflammatory bowel disease is believed to be caused by a combination of genetic and environmental stimuli such as our diet. Diets high in meat and fats and low in fruits and vegetables have been associated with new-onset inflammatory bowel disease. This has triggered interest in using dietary modification as a treatment. The 3 principle models of dietary intervention are supplementation with selected dietary components, exclusion of selected dietary components, or use of dietary formulas in place of a normal diet. Despite the high level of interest in dietary interventions as a treatment for inflammatory bowel disease, few well-designed clinical trials have been conducted to firmly establish the optimal diet to induce or maintain remission. This may be in part related to the challenges of conducting dietary intervention trials. This review examines these challenges and potential approaches to be used in dietary intervention trials.
炎症性肠病被认为是由遗传和环境刺激因素共同引起的,比如我们的饮食。肉类和脂肪含量高而水果和蔬菜含量低的饮食与新发炎症性肠病有关。这引发了人们对将饮食调整作为一种治疗方法的兴趣。饮食干预的3种主要模式是补充特定饮食成分、排除特定饮食成分或使用饮食配方替代正常饮食。尽管人们对饮食干预作为炎症性肠病的一种治疗方法兴趣浓厚,但很少有精心设计的临床试验来确定诱导或维持缓解的最佳饮食。这可能部分与进行饮食干预试验的挑战有关。本综述探讨了这些挑战以及饮食干预试验中可能采用的方法。